Clinical trials in Odense – page 20

487 clinical trials in Odense, Denmark across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in DenmarkKliniske-Forsoeg.dk

Odense at a glance

487

clinical trials

Research sites4

Quick filters

487 trials in Odense

Open in trial search

Small cell lung cancer limited stage

Not yet recruiting

Durvalumab after chemoradiation for patients with limited‑stage small cell lung cancer: a randomized trial of high‑dose versus standard thoracic radiation

Registered drugNo placebo

Durvalumab after chemoradiation for patients with limited‑stage small cell lung cancer: a randomized trial of high‑dose versus standard thoracic radiation

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Durvalumab
Sponsor:Norwegian University Of Science And Technolology

Contact Research Centre

Breast cancer

Not yet recruiting

Phase II Study of [68Ga]Ga-FAP-2286 PET/CT for Staging and Restaging Newly Diagnosed Primary Breast Cancer Patients

InvestigationalNo placebo

Phase II Study of [68Ga]Ga-FAP-2286 PET/CT for Staging and Restaging Newly Diagnosed Primary Breast Cancer Patients

InvestigationalNo placebo

Denmark

Participants:18–64 years · 65+ years
Sponsor:Odense University Hospital

Contact Research Centre

Autoimmune haemolytic anaemia+3

Not yet recruiting

Study of cc-97540 CD19‑Targeted NEX‑T CAR T in participants with chronic immune thrombocytopenia and autoimmune hemolytic anemia

InvestigationalNo placebo

Study of cc-97540 CD19‑Targeted NEX‑T CAR T in participants with chronic immune thrombocytopenia and autoimmune hemolytic anemia

InvestigationalNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:CC-97540
Sponsor:Celgene Corp.

Contact Research Centre

HIV infection

Not yet recruiting

Durable HIV-1 control with 10-1074-LS, 3BNC117-LS and nivolumab in adults on ART: a randomized double‑blind placebo‑controlled trial

Registered drug

Durable HIV-1 control with 10-1074-LS, 3BNC117-LS and nivolumab in adults on ART: a randomized double‑blind placebo‑controlled trial

Registered drug

Denmark

Participants:18–64 years
Substances:Nivolumab
Sponsor:Region Midtjylland

Contact Research Centre

Migraine without aura

Not yet recruiting

Study of apremilast‑induced headache and migraine in women with migraine without aura

Registered drug

Study of apremilast‑induced headache and migraine in women with migraine without aura

Registered drug

Denmark

Participants:18–64 years
Substances:Apremilast
Sponsor:Syddansk Universitet (University of Southern Denmark)

Contact Research Centre

Cardiovascular disorder

Not yet recruiting

Rosuvastatin zinc 20 mg for patients with cardiovascular disease and statin intolerance: a trial comparing continuation after a 36‑week N‑of‑1 self‑assessment versus standard care

Registered drug

Rosuvastatin zinc 20 mg for patients with cardiovascular disease and statin intolerance: a trial comparing continuation after a 36‑week N‑of‑1 self‑assessment versus standard care

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Rosuvastatin Zinc
Sponsor:Copenhagen University Hospital

Contact Research Centre

Plasma cell myeloma refractory+1

Not yet recruiting

Dose optimization study of ibrutinib drug combination in adult patients with haematological diseases

Registered drugNo placebo

Dose optimization study of ibrutinib drug combination in adult patients with haematological diseases

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Elranatamab
Sponsor:Rigshospitalet

Contact Research Centre

Osteogenesis imperfecta

Not yet recruiting

Phase 2 Study of AGA2115 in Adults with Osteogenesis Imperfecta (COL1A1/COL1A2 Variants) Evaluating Bone Density

Investigational

Phase 2 Study of AGA2115 in Adults with Osteogenesis Imperfecta (COL1A1/COL1A2 Variants) Evaluating Bone Density

Investigational

Denmark

Participants:18–64 years · 65+ years
Sponsor:Angitia Inc. Ltd.

Contact Research Centre

Interstitial lung disease+2

Not yet recruiting

Long‑term Safety and Tolerability of Admilparant in Adults with Idiopathic or Progressive Pulmonary Fibrosis

InvestigationalNo placebo

Long‑term Safety and Tolerability of Admilparant in Adults with Idiopathic or Progressive Pulmonary Fibrosis

InvestigationalNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Admilparant
Sponsor:Bristol-Myers Squibb Services Unlimited Company

Contact Research Centre

Rheumatoid arthritis

Not yet recruiting

Effect of High‑Dose Thiamine Hydrochloride on Fatigue in Rheumatoid Arthritis Patients: Randomized, Double‑Blind, Placebo‑Controlled Trial

Registered drug

Effect of High‑Dose Thiamine Hydrochloride on Fatigue in Rheumatoid Arthritis Patients: Randomized, Double‑Blind, Placebo‑Controlled Trial

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Thiamine Hydrochloride
Sponsor:Odense University Hospital

Contact Research Centre

Pulmonary embolism

Not yet recruiting

Enoxaparin or drug combination versus no anticoagulant treatment for incidental subsegmental pulmonary embolism in cancer patients

Registered drugNo placebo

Enoxaparin or drug combination versus no anticoagulant treatment for incidental subsegmental pulmonary embolism in cancer patients

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Apixaban
Sponsor:Region Hovedstaden

Contact Research Centre

Pancreatitis chronic

Not yet recruiting

Celecoxib versus placebo for pain and quality of life in adult patients with chronic pancreatitis

Registered drug

Celecoxib versus placebo for pain and quality of life in adult patients with chronic pancreatitis

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Celecoxib
Sponsor:Odense University Hospital

Contact Research Centre

Other cities in Denmark

The busiest research cities in the country

All 48 cities in Denmark

Clinical research in Odense

What the registry says about research in the country

01 Respiratory and Pulmonary Research

Clinical investigations focusing on Idiopathic Pulmonary Fibrosis and chronic respiratory conditions. Studies evaluating new therapeutic approaches for managing nasal polyps and chronic rhinosinusitis.

Pulmonary Fibrosis Treatment
Nasal Polyps Management
Chronic Rhinosinusitis

Trials aim to assess innovative treatments and monitor long-term disease control.

02 Oncology Studies

Comprehensive research into various cancer types, including bladder cancer, metastatic breast cancer, and prostate cancer. Focus on innovative therapies and treatment combinations.

Cancer-Related Fatigue
Advanced Breast Cancer
Prostate Cancer Therapy

Studies evaluate novel treatment approaches and drug combinations for better patient outcomes.

03 Autoimmune and Inflammatory Conditions

Research focusing on Inflammatory Bowel Disease, including Crohn's Disease and Ulcerative Colitis. Studies of treatments for Sjögren's Syndrome and immune thrombocytopenia.

Gastrointestinal Disorders
Immune System Disorders
Chronic Inflammatory Conditions

Trials assess both established and experimental therapies for inflammatory conditions.

04 Cardiovascular and Renal Studies

Investigations into chronic kidney disease, heart conditions, and transplant outcomes. Research includes studies on aortic stenosis and myocardial infarction treatments.

Kidney Transplantation
Cardiac Conditions
Renal Disorders

Focus on improving treatment outcomes and patient care in cardiovascular and renal conditions.

Back to Denmark All countries